Cargando…
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19
SARS-CoV-2, the agent responsible for COVID-19, has wreaked havoc around the globe. Hundreds of millions of individuals have been infected and well over six million have died from COVID-19. Many COVID-19 survivors have ongoing physical and psychiatric morbidity, which will remain for the rest of the...
Autores principales: | Ameratunga, Rohan, Leung, Euphemia, Woon, See-Tarn, Lea, Edward, Allan, Caroline, Chan, Lydia, Steele, Richard, Lehnert, Klaus, Longhurst, Hilary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554200/ https://www.ncbi.nlm.nih.gov/pubmed/36241155 http://dx.doi.org/10.1016/j.jaip.2022.10.002 |
Ejemplares similares
-
SARS-CoV-2 Omicron: Light at the End of the Long Pandemic Tunnel or Another False Dawn for Immunodeficient Patients?
por: Ameratunga, Rohan, et al.
Publicado: (2022) -
Common Variable Immunodeficiency Disorders, T-Cell Responses to SARS-CoV-2 Vaccines, and the Risk of Chronic COVID-19
por: Ameratunga, Rohan, et al.
Publicado: (2021) -
Are All Primary Immunodeficiency Disorders Inborn Errors of Immunity?
por: Ameratunga, Rohan, et al.
Publicado: (2021) -
Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium
por: Demoly, Pascal, et al.
Publicado: (2018) -
SARS-CoV-2 Pandemic Impacts on NASA Ground Operations to Protect ISS Astronauts
por: Makedonas, George, et al.
Publicado: (2020)